How Confident Should We Be?
Dear Editor: Winkelmann et al[1] presented evidence on the usefulness of multispectral digital skin lesion analysis (MelaFind®; MELA Sciences, Inc.) as an aid in evaluating pigmented lesions (PLs) that have
Dear Editor: Winkelmann et al[1] presented evidence on the usefulness of multispectral digital skin lesion analysis (MelaFind®; MELA Sciences, Inc.) as an aid in evaluating pigmented lesions (PLs) that have
aJames H. Herndon, Jr, MD, FAAD; bElizabeth T. Makino, BS, CCRA, MBA; aLily I. Jiang, PhD; aThomas J. Stephens, PhD; bRahul C. Mehta, PhD aThomas J. Stephens & Associates, Richardson,
Guy Webster, MD, PhD Department of Dermatology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania Disclosure: Dr. Webster is a consultant for Janssen, Galderma, and Valeant. Abstract
aAnna D. Holmes, PhD; aKimberly A. Waite, BS; aMichael C. Chen, PhD; aKiruthi Palaniswamy, PharmD; aThomas H. Wiser, PharmD; bZoe D. Draelos, MD; cElyse S. Rafal, MD; dW. Philip Werschler,
aJoshua P. Fogelman, MD; bMary L. Stevenson, MD; b,cRobin Ashinoff, MD; bNicholas A. Soter, MD aDepartment of Dermatology, Columbia University, and Dermatology Center of Rockland, P.C., New York, New York,